What is Covidien Dividend Payout Ratio?
Covidien's dividend payout ratio for the
months ended in Dec. 2014 was 0.32.
The historical rank and industry rank for Covidien's Dividend Payout Ratio or its related term are showing as below:
FRA:6COP'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.19 Med: 0.28 Max: 1.43
Current: 0.43
During the past 13 years, the highest Dividend Payout Ratio of Covidien was 1.43. The lowest was 0.19. And the median was 0.28.
As of today (2024-05-07), the Dividend Yield % of Covidien is 1.13%.
During the past 13 years, the highest Trailing Annual Dividend Yield of Covidien was 2.51%. The lowest was 0.39%. And the median was 1.69%.
Covidien's Dividends per Share for the
months ended in Dec. 2014 was €0.29.
During the past 12 months, Covidien's average Dividends Per Share Growth Rate was 100.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 39.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 23.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Covidien was 66.60% per year. The lowest was 0.00% per year. And the median was -1.05% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Covidien Dividend Payout Ratio Historical Data
The historical data trend for Covidien's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covidien Dividend Payout Ratio Chart
|
Covidien Annual Data
|
|
Trend |
Sep05 |
Sep06 |
Sep07 |
Sep08 |
Sep09 |
Sep10 |
Sep11 |
Sep12 |
Sep13 |
Sep14 |
| Dividend Payout Ratio |
|
Get a 7-Day Free Trial
|
|
|
0.07 |
0.16 |
0.27 |
0.31 |
0.45 |
|
Covidien Quarterly Data
|
|
Mar10 |
Jun10 |
Sep10 |
Dec10 |
Mar11 |
Jun11 |
Sep11 |
Dec11 |
Mar12 |
Jun12 |
Sep12 |
Dec12 |
Mar13 |
Jun13 |
Sep13 |
Dec13 |
Mar14 |
Jun14 |
Sep14 |
Dec14 |
| Dividend Payout Ratio |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
0.37 |
0.33 |
0.48 |
0.60 |
0.32 |
Competitive Comparison of Covidien's Dividend Payout Ratio
For the Medical Instruments & Supplies subindustry, Covidien's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Covidien's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Covidien's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Covidien's Dividend Payout Ratio falls into.
Covidien Dividend Payout Ratio Calculation
Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.
Covidien's Dividend Payout Ratio for the fiscal year that ended in Sep. 2014 is calculated as
Covidien's Dividend Payout Ratio for the quarter that ended in Dec. 2014 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Covidien (FRA:6COP) Business Description
Traded in Other Exchanges
N/A
Address
Covidien PLC formerly known as Covidien Ltd. was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. In June 2009, Covidien plc announced that one of its subsidiaries has completed the acquisition of VNUS Medical Technologies, Inc. In September 2009, the Company completed the acquisition of Power Medical Interventions Inc. In November 2009, the Company completed the acquisition of Aspect Medical Systems Inc. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States. Its mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals. It operates through two segments: Medical Devices and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. The Medical Supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products. Competitors of Medical Devices segment include diversified healthcare companies, such as Johnson & Johnson, Boston Scientific, Baxter and C.R. Bard. Its Nursing Care products include: Curity and Kerlix and Medical Surgical products include: Medi-Trace. The Company holds more than 13,000 patents and have over 10,500 patent applications pending in the United States and in certain other countries that relate to aspects of the technology used in many of its products. The Company is subject to numerous federal, state and local environmental protection and health and safety laws and regulations both within and outside the United States.
Covidien (FRA:6COP) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:6COP has been successfully added to your